Press Release
DIACTMOND project: presenting final prototype
Huge news on DIACTMOND PROJECT: we are happy to announce that we reached final phase of the work on DIACTMOND PROJECT – after successful testing in collaboration with our clinical partners at the Nicosia General Hospital, Embio Diagnostics’ scientists presented a...
Food For Future Summit – Dubai Expo 2020
Embio Diagnostics was invited as a FOODTECH 500 company to exhibit at the Food For Future Summit that took place in February in Dubai Expo 2020. It has been a great experience meeting, networking and exploring business opportunities with leading international...
EMBIO Diagnostics: Η επόμενη μέρα μετά από το deal με την ASBIS
Τα νέα δεδομένα και τις προοπτικές μετά την στρατηγική επένδυση ύψους €1 εκατ. από την ΑSBISc Enterprises Plc αναλύει ο Διευθύνων Σύμβουλος και Ιδρυτής της EMBIO Diagnostics. Σε συνέντευξή του στο InBusinessNews, ο Κωνσταντίνος Λοΐζου σημειώνει ότι η συμφωνία με τον...
EMBIO Diagnostics receives €1m funding from ASBIS Group to accelerate growth and enter new global markets
The Cypriot biotech company completes a successful seed funding round, to enter new markets with its revolutionary diagnostic multi-functional devices. EMBIO Diagnostics Ltd announced today a strategic investment of €1m from ASBIS Group. ASBISc Enterprises Plc, is a...
Foodtech 500 – EMBIO Diagnostics Selection as 2020 Finalist
We are thrilled to announce that EMBIO Diagnostics Ltd have been selected as a finalist for this year’s @ForwardFooding #FoodTech500, the world’s first definitive list of the global entrepreneurial talent at the intersection between food, technology, and...
BELD is now introduced in another lab
BELD is introduced and integrated in another State of the Art laboratory in Cyprus. The Biorheology Laboratory at the Department of Mechanical Engineering and Materials Science and Engineering of the Cyprus University of Technology. With research interests that...